Affiliation:
1. Department of Internal Medicine, Breast Oncology Program, University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, USA
Abstract
Learning Objectives
After completing this course, the reader will be able to: Identify the difference between prognostic and predictive factors.Describe the evaluation of tumor markers, including their utility, magnitude, and reliability.Discuss issues surrounding tumor markers currently in routine use in breast cancer, including estrogen receptor, Her-2/neu, and Oncotype DX™.
Access and take the CME test online and receive 1 AMA PRA category 1 credit at CME.TheOncologist.com
Publisher
Oxford University Press (OUP)
Cited by
114 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献